Mebilax 15 DHG medicine treats musculoskitis (2 blisters x 10 tablets)

Dosage form Box of 2 blisters x 10 tablets
Specifications Meloxicam

Ingredient

Composition information	Content
Meloxicam	15mg

Uses

Indications

Mebilax 15 drugs are indicated in cases where the following chronic painful symptoms:

Osteoarthritis pain (joint damage, osteoarthritis).

rheumatoid arthritis.

A joint spine inflammation.

Pharmacy

Mebilax with active ingredient Meloxicam is an anti -inflammatory drug nonsteroid, Oxicam derivatives, anti -inflammatory, analgesic and antipyretic effect. The general mechanism of the above effects is because Meloxicam has the ability to inhibit biosynthesis of prostaglandin, intermediate substances that cause inflammation, pain and fever.

pharmacokinetic pharmacokinetics

Meloxicam absorb well after oral oral abuse, average about 89%. The drug is strongly linked to plasma proteins, mainly albumin. Meloxicam is strongly metabolized in the liver, half is eliminated through the urine and half in the stool. The average disposal time is 20 hours.

Before taking Mebilax 15 DHG medicine treats musculoskitis (2 blisters x 10 tablets)

How to use

Drugs used by oral.

Dosage

rheumatoid arthritis, joint spondylitis:

15mg (1 tablet/day). Depending on the response, the dose can be reduced to 7.5mg/day.

Acute pain of osteoarthritis:

7.5mg/ day. If necessary, the dose can be increased to 15 mg (1 tablet/day).

Patients with high risk of side effects, elderly people:

Starting for treatment at a dose of 7.5mg/day.

Patients with dialysis:

Use no more than 7.5 mg/day. Patients with severe renal failure.

Children under 18 years old:

has not determined the safety and effectiveness of children under 18 years of age.

or as directed by a physician

Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.

What to do when overdose? There is currently no specific antidote. In a clinical experiment, using cholestyramin will increase the elimination of meloxicam. Severe injuries on the gastrointestinal tract can be treated with antacids and antihistamine H2.

What to do when you forget a dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Note that it should not be used double the prescribed dose.

Side Effects

When using Mebilax 15, you may experience unwanted effects (ADR).

Common

digestive disorders;

nausea;

Phu.

less common

Increase the transaminase, bilirubin;

belching;

flushed;

increased creatinine and blood urea;

Rare

Colitis, gastric ulcer, duodenum, hepatitis, gastritis;

increase skin sensitivity to light;

Bronchial asthma attacks;

Instructions on how to handle ADR

Notify the doctor with unwanted effects when using the drug.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

Contraindicated

Mebilax 15 drugs against in the following cases:

allergies to the ingredients of the drug.

Not for patients with allergies to aspirin and other NSAIDs.

Bronchial asthma, nasal polyps, nerve angiema, Quincke edema, urticaria after taking aspirin and other NSAIDs, stomach ulcers, progressive duodenum, stomach bleeding, brain bleeding.

severe liver failure. Severe kidney failure is not appraised.

Pregnant and lactating women.

Caution when using

Caution for patients with above gastrointestinal diseases or being treated with anticoagulant drugs. Must stop using Mebilax if there is a peptic ulcer or gastrointestinal bleeding.

Meloxicam should be avoided in case of severe liver failure, bleeding disorders or patients with severe renal impairment. Meloxicam dose of patients with end -stage renal failure must not exceed 7.5mg/day. Mild or moderate renal failure does not need to reduce the dose. Medication should be stopped and monitored if there is a significant increase in serum transaminase or other liver function parameters.

Heart thrombosis

Non -steroid anti -inflammatory drugs (NSAIDs), non -aspirin, use systemic sugar, may increase the risk of cardiovascular thrombosis, including myocardial infarction and stroke, which can lead to death. This risk can appear early in the first few weeks of taking the drug and can increase over time. The risk of cardiovascular thrombosis is recorded mainly at high doses.

Doctors need to periodically evaluate the appearance of cardiovascular events, even if the patient has no previous cardiovascular symptoms. Patients need to be warned of symptoms of serious cardiovascular events and need to see a doctor as soon as they appear. To minimize the risk of adverse incidents, it is necessary to use Mebilax 15 at the lowest daily dose effective in the shortest possible time.

The ability to drive and operate machinery

The drug can cause unwanted effects such as dizziness, drowsiness so it is best not to use Meloxicam while participating in these activities.

Pregnancy

There is no evidence of Meloxicam's teratogenic evidence. However, Meloxicam is recommended not for pregnant women, especially in the last 3 months of pregnancy.

Breastfeeding period

Do not use meloxicam during breastfeeding.

Medicinal interaction

in combination with other nonsteroidal anti -inflammatory drugs increases the risk of ulcers, gastrointestinal bleeding. Coordinate with anticoagulants, thrombolytic drugs that increase the risk of bleeding.

Meloxicam increases blood lithium content and increases the blood toxicity of methotrexate and toxicity on the body of cyclosporin. Used with diuretics increases the likelihood of acute renal failure in dehydration patients.

Meloxicam reduces the effects of antihypertensive drugs.

Storage

In a dry place, the temperature does not exceed 30 ° C, avoiding light.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.